Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
Light and sound therapy may fend off memory and cognitive damage for chemo patients
By
Aaron Dorman
Mar 08, 2024
A combination of light and sound therapy may be able to counteract the problems in the brain caused by chemo, new research shows.
Aegis Living, SLR recognized for achieving elevated memory care standards
By
Kimberly Bonvissuto
Feb 26, 2024
Two assisted living and memory care providers have earned certifications for meeting elevated standards of care for people living with dementia.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Holistic dementia care reduces staff burdens, enhances provider market position
By
Paul Tanico
Feb 01, 2024
By adopting a comprehensive strategy that balances clinical insights, lifestyle interventions and economic considerations, staff members can unlock the potential for improved outcomes and elevate the facility’s...
Arizona legislators call for more transparency, improved safety in assisted living
By
Kimberly Bonvissuto
Jan 30, 2024
Arizona has joined a growing list of states where governments are calling for more transparency from assisted living communities through legislation following local media reports questioning resident safety...
Assisted living, memory care operators elevate dementia caregiving
By
Kimberly Bonvissuto
Jan 03, 2024
Two senior living communities have launched initiatives to elevate care for residents living with dementia and other cognitive issues.
Non-invasive brain tech joining drug solutions among emerging Alzheimer’s treatments
By
Aaron Dorman
Dec 07, 2023
Memory functions of people living with Alzheimer’s disease can significantly improve from twice-daily, long-term use of brain stimulation, new research shows.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
High-tech ‘bike-helmet’ part of emerging field of light therapy for dementia, Alzheimer’s
By
Aaron Dorman
Nov 16, 2023
Light therapy is one way that seniors can both maintain and monitor their brain and cognitive function, one tech company co-founder says.